Related Experiment Video

Updated: May 6, 2026

Neurodegeneration in an Animal Model of Chronic Amyloid-beta Oligomer Infusion Is Counteracted by Antibody Treatment Infused with Osmotic Pumps
10:19

Neurodegeneration in an Animal Model of Chronic Amyloid-beta Oligomer Infusion Is Counteracted by Antibody Treatment Infused with Osmotic Pumps

Published on: August 14, 2016

11.0K

Neurodegenerative disease: Neurodegeneration halted with oral therapy in mice

Bryony Jones

    Nature Reviews. Neurology
    |November 6, 2013
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Intracerebroventricular Injection of Amyloid-β Peptides in Normal Mice to Acutely Induce Alzheimer-like Cognitive Deficits
    08:01

    Intracerebroventricular Injection of Amyloid-β Peptides in Normal Mice to Acutely Induce Alzheimer-like Cognitive Deficits

    Published on: March 16, 2016

    42.5K
    Stereotaxic Infusion of Oligomeric Amyloid-beta into the Mouse Hippocampus
    08:16

    Stereotaxic Infusion of Oligomeric Amyloid-beta into the Mouse Hippocampus

    Published on: June 17, 2015

    18.4K

    Related Experiment Videos

    Last Updated: May 6, 2026

    Neurodegeneration in an Animal Model of Chronic Amyloid-beta Oligomer Infusion Is Counteracted by Antibody Treatment Infused with Osmotic Pumps
    10:19

    Neurodegeneration in an Animal Model of Chronic Amyloid-beta Oligomer Infusion Is Counteracted by Antibody Treatment Infused with Osmotic Pumps

    Published on: August 14, 2016

    11.0K
    Intracerebroventricular Injection of Amyloid-β Peptides in Normal Mice to Acutely Induce Alzheimer-like Cognitive Deficits
    08:01

    Intracerebroventricular Injection of Amyloid-β Peptides in Normal Mice to Acutely Induce Alzheimer-like Cognitive Deficits

    Published on: March 16, 2016

    42.5K
    Stereotaxic Infusion of Oligomeric Amyloid-beta into the Mouse Hippocampus
    08:16

    Stereotaxic Infusion of Oligomeric Amyloid-beta into the Mouse Hippocampus

    Published on: June 17, 2015

    18.4K

    Related Concept Videos

    Alzheimer's Disease: Treatment01:22

    Alzheimer's Disease: Treatment

    1.3K
    Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
    1.3K

    Articles linked to this work by shared authors, journal, and citation graph.

    Impact of Removing the Monitoring Requirements for Holdings with Atypical Scrapie in Great Britain.

    Animals : an open access journal from MDPI·2025

    Increased glycemic variability in pregnant women with Roux-en-Y gastric bypass compared with sleeve gastrectomy.

    BMJ open diabetes research & care·2024

    Dual biologic therapy for the treatment of rheumatic diseases and asthma: a case series.

    Rheumatology advances in practice·2023

    Managing liver fluke on hill farms.

    The Veterinary record·2022

    Uterine Transplantation: Review of Livebirths and Reproductive Implications.

    Transplantation·2020

    European Reference Network for Rare Vascular Diseases (VASCERN) position statement on cerebral screening in adults and children with hereditary haemorrhagic telangiectasia (HHT).

    Orphanet journal of rare diseases·2020

    The emerging role of microbiota in neuro-oncology.

    Nature reviews. Neurology·2026

    Atypical Alzheimer disease: a multi-axis framework toward defining heterogeneity.

    Nature reviews. Neurology·2026

    Somatic mosaicism in the brain: linking development, ageing and neurodegeneration.

    Nature reviews. Neurology·2026

    Cortical lesions in multiple sclerosis: 25 years of progress, remaining challenges and future directions.

    Nature reviews. Neurology·2026

    Role of complement and complement-targeted therapeutics in neurological diseases.

    Nature reviews. Neurology·2026

    Symptomatic treatment for Alzheimer disease: current evidence and future directions.

    Nature reviews. Neurology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us